CIRS (Computerized Imaging Reference Systems, Inc.) Competitors

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Digirad® is the OEM imaging brand of Catalyst MedTech, delivering innovative nuclear medicine imaging systems designed to help providers expand access, modernize technology and support high-quality patient care. A pioneer in solid-state nuclear imaging, Digirad helped break the traditional “tube-based barrier” and today builds on generations of imaging innovation with an expanded portfolio spanning cardiac and general nuclear medicine. The Digirad portfolio includes the Cardius® Series, X-ACT+®, CorCam™, QuantumCam™ and Ergo™, bringing together dedicated cardiac SPECT, attenuation correction, versatile general nuclear medicine imaging and portable imaging solutions. Backed by Catalyst MedTech’s nationwide service and support infrastructure, Digirad combines OEM innovation, clinical expertise and long-term lifecycle support to help imaging providers get more from their technology today while preparing for what comes next. Digirad® | A Catalyst MedTech Company See What’s Possible.

Blue Earth Diagnostics, a subsidiary of Bracco Imaging, is a global company advancing precision molecular imaging to support timely decisions and better patient outcomes. Founded in 2014, we work closely with clinicians and collaborators, bringing deep expertise to the development and delivery of positron emission tomography (PET) radiopharmaceuticals. Our growing portfolio helps uncover disease sooner and guide treatment choices across multiple disease states, including oncology and cardiology. Backed by a dedicated team, we deliver clear answers when decisions matter most.